Gulf War Syndrome Clinical Trial
Official title:
Telemedicine Treatment for Veterans With Gulf War Illness
Verified date | June 2017 |
Source | VA Office of Research and Development |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Effective treatments have been developed to ameliorate symptom-related distress and reduce unnecessary healthcare utilization using cognitive-behavioral techniques (CBT) . However there is a major limitation of this treatment is that patients must attend sessions in person. The specific aims of the study are to: (1) Determine the clinical efficacy of Telephone CBT for veterans with GWI who are frequent consumers of ambulatory medical care; (2) Determine whether CBT for veterans with GWI leads to a reduction in the cost of VA health care; and (3) Develop a statistical model of treatment seeking in veterans with GWI who are frequent consumers of ambulatory medical care.
Status | Completed |
Enrollment | 128 |
Est. completion date | March 1, 2008 |
Est. primary completion date | February 22, 2008 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Top 20% of medical care utilizers; - Satisfies criteria for multisymptom illness; - Enrolled in the New Jersey VA Healthcare System for at least one year Exclusion Criteria: - Psychotic disorders; - Dementia or other cognitive disorders; - Brain damage; - Anorexia/other eating disorders; - Pregnancy; - Heart failure; - Cancer; - Chronic renal insufficiency; - Severe hepatic disease; - Active Substance Abuse/Dependence |
Country | Name | City | State |
---|---|---|---|
United States | East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ | East Orange | New Jersey |
Lead Sponsor | Collaborator |
---|---|
VA Office of Research and Development |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Frequency of medical visitation | 12 months | ||
Secondary | quality of life | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00100412 -
Hyporeactivity and Gulf War Illness
|
N/A | |
Recruiting |
NCT04182659 -
Long Term Efficacy of Neuronavigation Guided rTMS in Alleviating Gulf War Illness Related Headaches and Pain Symptoms
|
N/A | |
Recruiting |
NCT04987775 -
GWICTIC: NAC Mechanistic Study in Gulf War Veterans
|
Early Phase 1 | |
Completed |
NCT03342482 -
Glutamate Neuro-Excitotoxicity in GWI
|
N/A | |
Completed |
NCT01264471 -
Mechanisms of Mitochondrial Defects in Gulf War Syndrome
|
N/A | |
Terminated |
NCT03547869 -
Transcranial Direct Current Stimulation for Pain Treatment in Gulf War Illness.
|
N/A | |
Recruiting |
NCT05675878 -
Confirmation of Diet as a Treatment for Gulf War Illness
|
Phase 3 | |
Recruiting |
NCT05736146 -
Validating Gulf War Illness Blood Biomarkers
|
||
Completed |
NCT03560830 -
START & STOPP in GWI
|
||
Recruiting |
NCT05355272 -
Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)
|
Phase 2 | |
Terminated |
NCT04712071 -
Ketamine in Veterans With Gulf War Illness
|
Early Phase 1 | |
Completed |
NCT03030794 -
Alleviating Headache and Pain in GWI With Neuronavigation Guided rTMS
|
N/A | |
Completed |
NCT04638998 -
Assessing Neuroinflammation in GWI Using MRS
|
||
Completed |
NCT02804828 -
Mitochondrial Cocktail for Gulf War Illness
|
N/A | |
Recruiting |
NCT02848417 -
Glutathione vs. Curcumin Clinical Trial
|
Phase 1/Phase 2 | |
Recruiting |
NCT00956150 -
Bacterial Overgrowth Associated With Chronic Multisymptom Illness Complex
|
Phase 1 | |
Completed |
NCT00018707 -
Follow-up of Psychological and Neurocognitive Gulf War Outcome: Relation to Stress
|
N/A | |
Not yet recruiting |
NCT05992311 -
Clinical Evaluation of Montelukast in Veterans With Gulf War Illness
|
Phase 1 |